MedPath

effect of simple zofa (hyssopus officinalis) syrup on persistant asthma

Phase 3
Recruiting
Conditions
persistent asthma.
Predominantly allergic asthma
Registration Number
IRCT20110811007297N5
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

older than 18 years old patients
confirm of disease by internist. diagnosis criteria: acording to NAEP EPR3 criteria for persistant asthma disease: FEV1: 60-80%

Exclusion Criteria

history of allergy to plant of mint family
dissatisfaction of treatment in each stage
side effect development through treatment
theophylline cosumption
diabetic patients
convulsion history
pregnant patients
patienta that need to hospitalize
Exacerbation at beginning of study
smokers
diability in statement of symptom intensity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spirometry indicator: FEV1 and FEV1 /FVC. Timepoint: at the first of the study(before intervention) and 4 weeks after intervention. Method of measurement: spirometry set.;Asthma treatment investigation score(The Expert Panel Report 3 (EPR 3)). Timepoint: at the first of the study(before intervention) and 4 weeks after intervention. Method of measurement: asthma treatment investigation questionnaire (The Expert Panel Report 3 (EPR 3)).;Asthma control test(ACT) score. Timepoint: at the first of the study(before intervention) , 4 weeks and 8 week after intervention. Method of measurement: asthma control test questionnaire(ACT).
Secondary Outcome Measures
NameTimeMethod
Wheezing intensity determination. Timepoint: At the first of the study(before intervention) and 4 weeks after intervention. Method of measurement: History and physical exam with stethoscope.;Lung dystemperament. Timepoint: At the first of the study(before intervention) and 4 weeks after intervention. Method of measurement: Primary questionnaire of lung dystemperament investigation in terms of warm and cold and primary questionnaire of lung dystemperament investigation in terms of wet and drought.
© Copyright 2025. All Rights Reserved by MedPath